Condition
Short-coupled Ventricular Fibrillation
Total Trials
1
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
Treatment Research
2 treatments under study, led by Dpp6 Risk Haplotype
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Recruiting1
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Common Treatments
- Dpp6 Risk Haplotype1
- Repeat Plasma Screening For The Presence Or Absence Of Antitrek1 Autoantibodies1
Active Sponsors
- Institut universitaire de cardiologie et de pneumologie de Québec, University Laval1
Top Investigators
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Related Conditions
- Idiopathic Ventricular Fibrillation1